The impact of HER2 phenotype of circulating tumor cells in metastatic breast cancer: a retrospective study in 107 patients

BACKGROUND: In metastatic breast cancer (MBC), antigen profiles of metastatic tissue and primary tumor differ in up to 20 % of patients. Reassessment of predictive markers, including human epidermal growth factor receptor 2 (HER2) expression, might help to optimize MBC treatment. While tissue sampli...

Descripción completa

Detalles Bibliográficos
Autores principales: Wallwiener, Markus, Hartkopf, Andreas Daniel, Riethdorf, Sabine, Nees, Juliane, Sprick, Martin Ronald, Schönfisch, Birgitt, Taran, Florin-Andrei, Heil, Jörg, Sohn, Christof, Pantel, Klaus, Trumpp, Andreas, Schneeweiss, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435916/
https://www.ncbi.nlm.nih.gov/pubmed/25972110
http://dx.doi.org/10.1186/s12885-015-1423-6

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4435916/
https://www.ncbi.nlm.nih.gov/pubmed/25972110
http://dx.doi.org/10.1186/s12885-015-1423-6

Ejemplares similares